Literature DB >> 25484736

Crystal structure of 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidin-1-ium 3-hy-droxy-pyridine-2-carboxyl-ate.

Ammasai Karthikeyan1, Packianathan Thomas Muthiah1, Franc Perdih2.   

Abstract

The asymmetric unit of the title salt, C4H5FN3O(+)·C6H4NO3 (-), contains one 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidin-1-ium (5-fluoro-cytosinium, 5FC) cation and a 3-hy-droxy-picolinate (3HAP) anion. The 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidine mol-ecule is protonated at one of the pyrimidine N atoms. The typical intra-molecular N-H⋯F and O-H⋯O S(5) and S(6) hydrogen-bond ring motifs are observed in the cations and anions. The protonated N atom and 2-amine group of the 5FC cation inter-act with the 3HPA anion through a pair of nearly parallel N-H⋯O hydrogen bonds, forming a robust R 2 (2)(8) ring motif. The ions are further linked by N-H⋯N, O-H⋯O, N-H⋯O and C-H⋯O hydrogen bonds, generating R 2 (2)(7), R 3 (3)(12) and R 6 (5)(18) ring motifs, respectively, leading to supra-molecular wave-like sheets parallel to (010). The crystal structure is further stabilized by C-H⋯π inter-actions, generating a three-dimensional architecture.

Entities:  

Keywords:  5-fluorocytosine; anti­fungal drug; crystal structure; hydrogen bonding; hydrogen-bond ring motifs; supra­molecular structure

Year:  2014        PMID: 25484736      PMCID: PMC4257234          DOI: 10.1107/S1600536814021898

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Chemical context

Fluorinated pyrimidine and purine derivatives have received much inter­est because of their wide range of biological applications (Giner-Sorolla & Bendich, 1958 ▶). 5-Fuoro­cyto­sine is a fluorinated pyrimidine derivative anti-metabolite drug and is also extensively used as an anti-fungal agent for the treatment of Candida and Cryptococcus (Vermes et al., 2000 ▶). 5-Fluorocytosine is a versatile mol­ecule that plays essential roles in many biological applications, such as anti-tumour, potential gene therapy and gene-directed prodrug therapy (GDEPT) in the treatment of cancer (Kohila et al., 2012 ▶). The crystal structures of 5-fluoro­cytosine monohydrate, 5-fluorocytosine co-crystals and salts have also been reported (Louis et al., 1982 ▶; Tutughamiarso et al., 2012 ▶; Perumalla & Sun, 2014 ▶; Prabakaran et al., 2001 ▶). The crystal structures of various salts and complexes of 3-hy­droxy­picolinic acid have also been reported (Quintal et al., 2000 ▶; Soares-Santos et al., 2003 ▶; Betz and Gerber, 2011 ▶; Nirmalram et al., 2011 ▶). We report herein the mol­ecular structure of the title salt, formed from the reaction of 5-fluoro­cytosine with 3-hy­droxy­picoinic acid, namely 5-fluoro­cytosinium 3-hy­droxy­picolinate.

Structural commentary

The asymmetric unit contains a 5-fluoro­cytosinium cation and a 3-hy­droxy­picolinate anion (Fig. 1 ▶). The 5-fluoro­cytosine mol­ecule is protonated at N3, as is evident from the increase in the inter­nal angle at N3 from 120.8 (5) in neutral 5-fluoro­cytosine (Louis et al., 1982 ▶) to 124.85 (15)°. There is an intra­molecular N—H⋯F hydrogen bond with an S(5) ring motif between the N4 amino group and the F atom of the 5-fluoro­cytosinum cation. These hydrogen-bonding parameters are similar to those observed in 5-fluoro­cytosinium salicylate (Prabakaran et al., 2001 ▶). An intra­molecular O—H⋯O inter­action forms an S(6) motif between the phenolic OH and carboxyl­ate group, which is also observed in 3-hy­droxy­pyridinium-2-carboxyl­ate (Betz & Gerber, 2011 ▶).
Figure 1

The asymmetric unit of the title compound, showing 30% probability displacement ellipsoids. Dashed lines represent hydrogen bonds.

Supra­molecular features

In the crystal structure, the carboxyl­ate group of the 3-hy­droxy­picolinate anion (O3 and O4) inter­acts with the proton­ated N3 atom and the 4-amino group of the 5-fluoro­cytosinium moiety through a pair of N—H⋯O hydrogen bonds, forming a robust (8) motif (Etter, 1990 ▶; Bernstein et al., 1995 ▶). The 3-hy­droxy­picolinate (N2 and C12) atoms inter­act with the N1 atom and the exocyclic oxygen O2 atom of the 5-fluoro­cytosinium moiety through a pair of N—H⋯N and C—H⋯O hydrogen bonds, forming an (7) motif. This type of motif rarely occurs in cytosinium carboxyl­ate inter­actions (Benali-Cherif et al., 2009 ▶). The motif is further connected on the other side by (12) and (18) motifs formed (Bernstein et al., 1995 ▶) through C—H⋯O and N—H⋯O hydrogen bonds involving the O2 and N4 atoms of the 5-fluoro­cytosinium cation and the symmetry-related C6 atom of the another cytosinium cation and O1 atoms of 3-hy­droxy­picolinate anions, generating a wavy sheet-like structure parallel to (010) (Fig. 2 ▶). These wavy sheets are inter­connected via C10—H10⋯O2 hydrogen bonds (Fig. 3 ▶). The crystal structure is further stabilized by C—H⋯π inter­actions between 3-hy­droxy­picolinate anions, Table 1 ▶.
Figure 2

A view of the supra­molecular wavy sheet-like structure formed by N—H⋯F, O—H⋯O, N—H⋯O, N—H⋯N and C—H⋯O hydrogen bonds. Symmetry codes are given in Table 1 ▶. Dashed lines represent hydrogen bonds.

Figure 3

The wavy sheets inter­linked by C—H⋯O hydrogen bonds. Dashed lines represent hydrogen bonds (see Table 1 ▶ for details).

Table 1

Hydrogen-bond geometry (, )

Cg is the centroid of the N2/C8C12 ring.

DHA DHHA D A DHA
N1H1N2i 0.862.042.873(2)163
N3H3O40.861.852.6665(18)158
N4H4AO30.861.982.830(2)169
N4H4BO1ii 0.862.263.076(2)159
N4H4BF10.862.432.7312(18)101
O1H1AO30.821.832.5542(18)146
C6H6O2i 0.932.293.127(2)150
C10H10O3iii 0.932.543.272(2)136
C12H12O2iv 0.932.393.129(2)137
CllH11Cg1v 0.932.883.426(2)119

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) ; (v) .

Synthesis and crystallization

Hot aqueous solutions of 5-fluoro­cytosine (32 mg, Alfa Aesar) and 3-hy­droxy­picolinic acid (37 mg, Alfa Aesar) were mixed in a 1:1 molar ratio. The resulting solution was warmed over a water bath for half an hour and then kept at room temperature for crystallization. After a week, colourless prismatic crystals were obtained.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▶. All H atoms were initially located in difference Fourier maps and were subsequently treated as riding atoms in geometrically idealized positions, with C—H = 0.93, N—H = 0.86 and O—H = 0.83 Å, and with U iso(H) = 1.2U eq(C,N) and U iso(H) = 1.5U eq(O).
Table 2

Experimental details

Crystal data
Chemical formulaC4H5FN3O+C6H4NO3
M r 268.21
Crystal system, space groupOrthorhombic, P b c a
Temperature (K)293
a, b, c ()12.6487(4), 7.0786(2), 23.7200(6)
V (3)2123.77(10)
Z 8
Radiation typeMo K
(mm1)0.14
Crystal size (mm)0.15 0.05 0.05
 
Data collection
DiffractometerAgilent SuperNova (Dual, Cu at zero, Atlas)
Absorption correctionMulti-scan (CrysAlis PRO; Agilent, 2011)
T min, T max 0.979, 0.993
No. of measured, independent and observed [I > 2(I)] reflections8914, 2437, 1955
R int 0.027
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.042, 0.111, 1.08
No. of reflections2437
No. of parameters173
H-atom treatmentH-atom parameters constrained
max, min (e 3)0.24, 0.19

Computer programs: CrysAlis PRO (Agilent, 2011 ▶), SHELXS97 and SHELXL97 (Sheldrick, 2008 ▶) and PLATON (Spek, 2009 ▶).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814021898/tk5344sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814021898/tk5344Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814021898/tk5344Isup3.cml CCDC reference: 1027535 Additional supporting information: crystallographic information; 3D view; checkCIF report
C4H5FN3O+·C6H4NO3F(000) = 1104
Mr = 268.21Dx = 1.678 Mg m3
Orthorhombic, PbcaMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ac 2abCell parameters from 3551 reflections
a = 12.6487 (4) Åθ = 3.7–29.7°
b = 7.0786 (2) ŵ = 0.14 mm1
c = 23.7200 (6) ÅT = 293 K
V = 2123.77 (10) Å3Needle, colourless
Z = 80.15 × 0.05 × 0.05 mm
Agilent SuperNova (Dual, Cu at zero, Atlas) diffractometer2437 independent reflections
Radiation source: SuperNova (Mo) X-ray Source1955 reflections with I > 2σ(I)
Mirror monochromatorRint = 0.027
Detector resolution: 10.4933 pixels mm-1θmax = 27.5°, θmin = 3.2°
ω scansh = −16→11
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2011)k = −9→6
Tmin = 0.979, Tmax = 0.993l = −30→30
8914 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.042Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.111H-atom parameters constrained
S = 1.08w = 1/[σ2(Fo2) + (0.0458P)2 + 0.8599P] where P = (Fo2 + 2Fc2)/3
2437 reflections(Δ/σ)max < 0.001
173 parametersΔρmax = 0.24 e Å3
0 restraintsΔρmin = −0.19 e Å3
Experimental. 185 frames in 5 runs of ω scans. Crystal-detector distance = 55.0 mm.
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
F1−0.04979 (8)0.58078 (18)0.39473 (5)0.0483 (3)
N10.10109 (11)0.8014 (2)0.50442 (6)0.0335 (3)
H10.09090.84910.53730.040*
N30.21136 (11)0.7249 (2)0.42943 (6)0.0312 (3)
H30.27330.72390.41450.037*
N40.14821 (12)0.5828 (2)0.34880 (6)0.0392 (4)
H4A0.21080.58460.33470.047*
H4B0.09660.53600.32980.047*
O20.27785 (10)0.8667 (2)0.50714 (5)0.0446 (4)
C20.20128 (14)0.8021 (3)0.48270 (7)0.0317 (4)
C40.13147 (14)0.6513 (2)0.39922 (7)0.0296 (4)
C50.03071 (13)0.6548 (3)0.42474 (7)0.0332 (4)
C60.01722 (14)0.7286 (3)0.47624 (7)0.0346 (4)
H6−0.04960.72990.49260.041*
O10.49981 (11)0.4529 (2)0.24635 (5)0.0430 (4)
H1A0.44100.48330.25780.064*
O30.36400 (10)0.5738 (2)0.31741 (5)0.0408 (3)
O40.41321 (10)0.6570 (2)0.40413 (5)0.0416 (3)
N20.61308 (11)0.5297 (2)0.38561 (6)0.0296 (3)
C70.43231 (13)0.5915 (3)0.35634 (7)0.0301 (4)
C80.54219 (13)0.5251 (2)0.34318 (7)0.0274 (4)
C90.56959 (14)0.4572 (3)0.28970 (7)0.0306 (4)
C100.67182 (14)0.3927 (3)0.28059 (7)0.0347 (4)
H100.69180.34640.24550.042*
C110.74279 (14)0.3982 (3)0.32407 (7)0.0339 (4)
H110.81180.35650.31890.041*
C120.71035 (14)0.4669 (3)0.37608 (7)0.0332 (4)
H120.75890.46900.40550.040*
U11U22U33U12U13U23
F10.0265 (6)0.0690 (8)0.0494 (7)−0.0079 (5)−0.0027 (5)−0.0139 (6)
N10.0293 (8)0.0439 (9)0.0272 (7)0.0025 (7)0.0027 (6)−0.0036 (6)
N30.0221 (7)0.0427 (8)0.0288 (7)−0.0005 (6)0.0025 (5)−0.0008 (6)
N40.0295 (8)0.0552 (10)0.0330 (8)−0.0036 (8)0.0024 (6)−0.0086 (7)
O20.0291 (7)0.0668 (9)0.0379 (7)−0.0048 (7)−0.0022 (5)−0.0131 (7)
C20.0278 (9)0.0392 (9)0.0280 (8)0.0024 (8)0.0003 (7)0.0009 (7)
C40.0278 (9)0.0330 (9)0.0280 (8)0.0017 (7)−0.0008 (6)0.0039 (7)
C50.0238 (8)0.0406 (10)0.0351 (9)−0.0010 (8)−0.0034 (7)−0.0001 (8)
C60.0249 (8)0.0426 (10)0.0362 (9)0.0019 (8)0.0043 (7)0.0038 (8)
O10.0331 (7)0.0677 (9)0.0280 (6)0.0063 (7)−0.0043 (5)−0.0070 (6)
O30.0251 (6)0.0644 (9)0.0329 (7)0.0030 (6)−0.0020 (5)0.0009 (6)
O40.0275 (7)0.0623 (9)0.0349 (7)0.0053 (6)0.0032 (5)−0.0091 (6)
N20.0244 (7)0.0380 (8)0.0265 (7)−0.0016 (6)0.0002 (5)0.0011 (6)
C70.0247 (8)0.0361 (9)0.0294 (8)−0.0013 (7)0.0015 (7)0.0045 (7)
C80.0238 (8)0.0326 (9)0.0258 (8)−0.0020 (7)0.0014 (6)0.0024 (7)
C90.0292 (9)0.0367 (9)0.0258 (8)−0.0007 (8)−0.0012 (6)0.0007 (7)
C100.0357 (10)0.0394 (10)0.0290 (8)0.0047 (8)0.0048 (7)−0.0026 (7)
C110.0257 (9)0.0375 (9)0.0386 (9)0.0058 (8)0.0028 (7)0.0011 (8)
C120.0267 (9)0.0411 (10)0.0319 (9)0.0005 (8)−0.0030 (7)0.0012 (8)
F1—C51.348 (2)O1—C91.355 (2)
N1—C61.356 (2)O1—H1A0.8200
N1—C21.368 (2)O3—C71.271 (2)
N1—H10.8600O4—C71.248 (2)
N3—C41.344 (2)N2—C121.328 (2)
N3—C21.383 (2)N2—C81.348 (2)
N3—H30.8600C7—C81.500 (2)
N4—C41.308 (2)C8—C91.400 (2)
N4—H4A0.8600C9—C101.388 (2)
N4—H4B0.8600C10—C111.368 (2)
O2—C21.218 (2)C10—H100.9300
C4—C51.411 (2)C11—C121.388 (2)
C5—C61.340 (2)C11—H110.9300
C6—H60.9300C12—H120.9300
C6—N1—C2122.73 (15)C9—O1—H1A109.5
C6—N1—H1118.6C12—N2—C8118.75 (14)
C2—N1—H1118.6O4—C7—O3124.40 (16)
C4—N3—C2124.84 (15)O4—C7—C8118.99 (15)
C4—N3—H3117.6O3—C7—C8116.60 (15)
C2—N3—H3117.6N2—C8—C9121.32 (15)
C4—N4—H4A120.0N2—C8—C7116.96 (14)
C4—N4—H4B120.0C9—C8—C7121.70 (15)
H4A—N4—H4B120.0O1—C9—C10118.77 (15)
O2—C2—N1123.98 (16)O1—C9—C8122.25 (16)
O2—C2—N3120.68 (16)C10—C9—C8118.98 (15)
N1—C2—N3115.34 (15)C11—C10—C9118.99 (16)
N4—C4—N3120.63 (16)C11—C10—H10120.5
N4—C4—C5123.02 (16)C9—C10—H10120.5
N3—C4—C5116.34 (15)C10—C11—C12119.08 (16)
C6—C5—F1122.47 (16)C10—C11—H11120.5
C6—C5—C4120.85 (16)C12—C11—H11120.5
F1—C5—C4116.68 (15)N2—C12—C11122.87 (16)
C5—C6—N1119.89 (16)N2—C12—H12118.6
C5—C6—H6120.1C11—C12—H12118.6
N1—C6—H6120.1
C6—N1—C2—O2179.95 (18)C12—N2—C8—C7178.04 (16)
C6—N1—C2—N30.7 (3)O4—C7—C8—N24.0 (2)
C4—N3—C2—O2−179.68 (17)O3—C7—C8—N2−174.95 (16)
C4—N3—C2—N1−0.4 (3)O4—C7—C8—C9−177.49 (17)
C2—N3—C4—N4179.33 (17)O3—C7—C8—C93.6 (3)
C2—N3—C4—C50.0 (3)N2—C8—C9—O1−179.39 (16)
N4—C4—C5—C6−179.16 (18)C7—C8—C9—O12.2 (3)
N3—C4—C5—C60.2 (3)N2—C8—C9—C100.3 (3)
N4—C4—C5—F10.8 (3)C7—C8—C9—C10−178.17 (16)
N3—C4—C5—F1−179.85 (15)O1—C9—C10—C11179.43 (17)
F1—C5—C6—N1−179.86 (16)C8—C9—C10—C11−0.3 (3)
C4—C5—C6—N10.1 (3)C9—C10—C11—C120.4 (3)
C2—N1—C6—C5−0.5 (3)C8—N2—C12—C110.7 (3)
C12—N2—C8—C9−0.5 (3)C10—C11—C12—N2−0.7 (3)
D—H···AD—HH···AD···AD—H···A
N1—H1···N2i0.862.042.873 (2)163
N3—H3···O40.861.852.6665 (18)158
N4—H4A···O30.861.982.830 (2)169
N4—H4B···O1ii0.862.263.076 (2)159
N4—H4B···F10.862.432.7312 (18)101
O1—H1A···O30.821.832.5542 (18)146
C6—H6···O2i0.932.293.127 (2)150
C10—H10···O3iii0.932.543.272 (2)136
C12—H12···O2iv0.932.393.129 (2)137
Cll—H11···Cg1v0.932.883.426 (2)119
  7 in total

Review 1.  Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.

Authors:  A Vermes; H J Guchelaar; J Dankert
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Cocrystals of 5-fluorocytosine. I. Coformers with fixed hydrogen-bonding sites.

Authors:  Maya Tutughamiarso; Guido Wagner; Ernst Egert
Journal:  Acta Crystallogr B       Date:  2012-07-17

4.  Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.

Authors:  Sathyanarayana Reddy Perumalla; Changquan Calvin Sun
Journal:  J Pharm Sci       Date:  2014-02-11       Impact factor: 3.534

5.  Cytosinium-hydrogen maleate-cytosine (1/1/1).

Authors:  Nourredine Benali-Cherif; Wahiba Falek; Amani Direm
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-11

6.  3-Hy-droxy-pyridinium-2-carboxylate.

Authors:  Richard Betz; Thomas Gerber
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-16

7.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  7 in total
  2 in total

1.  Hydrogen-bonding patterns in 5-fluoro-cytosine-melamine co-crystal (4/1).

Authors:  Marimuthu Mohana; Packianathan Thomas Muthiah; Liurukara D Sanjeewa; Colin D McMillen
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-03-31

2.  Crystal structure and hydrogen-bonding patterns in 5-fluoro-cytosinium picrate.

Authors:  Marimuthu Mohana; Packianathan Thomas Muthiah; Colin D McMillen
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.